BHC vs IDYA: stock comparison and AI forecast
Bausch Health Companies Inc. (BHC) and Ideaya Biosciences, Inc. (IDYA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BHC Bausch Health Companies Inc.
- Price
- $8.02 +45.0% · 6M
- Market Cap
- $3.00B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
IDYA Ideaya Biosciences, Inc.
- Price
- $31.64 +9.5% · 6M
- Market Cap
- $3.05B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- BHC and IDYA have similar market capitalizations ($3.00B and $3.05B).
- Over the last six months BHC returned +45.0% and IDYA +9.5%.
- BHC turns -7.6% of its revenue into net income, against -74.8% for IDYA.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BHC | IDYA |
|---|---|---|
| Market Cap | $3.00B | $3.05B |
| P/B Ratio | – | 2.55x |
| EPS | $-2.05 | $-2.73 |
| Book Value/Share | – | $12.43 |
| Revenue/Share | $29.71 | $2.43 |
| FCF/Share | $4.99 | $-1.18 |
Profitability & Margins
| Metric | BHC | IDYA |
|---|---|---|
| ROE | – | -14.6% |
| ROA | -3.3% | -13.4% |
| ROIC | 6.0% | -17.7% |
| Operating Margin | 11.2% | -92.7% |
| Net Margin | -7.6% | -74.8% |
| EBT Margin | -3.2% | -92.7% |
| Tax Rate | -134.6% | 0.0% |
Financial Health
| Metric | BHC | IDYA |
|---|---|---|
| Current Ratio | 1.56x | 10.45x |
| Quick Ratio | 1.22x | – |
| D/E Ratio | – | 0.09x |
| Financial Leverage | – | 1.09x |
| Interest Coverage | 2.5x | 6551.7x |
| Working Capital | $2.66B | $781M |
Cash Flow
| Metric | BHC | IDYA |
|---|---|---|
| Operating Cash Flow | $2.21B | -$112M |
| Free Cash Flow | $1.86B | -$114M |
| Capital Spending | -$344M | -$2M |
| OCF Growth YoY | 46.7% | – |
| FCF Growth YoY | 70.3% | – |
| FCF/Sales | 16.8% | -48.6% |
| CapEx/Sales | 3.1% | 0.9% |
Operational Efficiency
| Metric | BHC | IDYA |
|---|---|---|
| Asset Turnover | 0.44x | 0.18x |
| Receivables Turnover | 4.4x | – |
| Fixed Assets Turnover | 5.3x | 28.3x |
| Days Sales Outstanding | 83 days | – |
Income Statement
| Metric | BHC | IDYA |
|---|---|---|
| Total Revenue | $11.11B | $234M |
| Operating Income | $1.25B | -$217M |
| Net Income | -$841M | -$175M |
| R&D Expense | $638M | $374M |
| SG&A Expense | $3.48B | – |
Dividend & Shareholder Information
| Metric | BHC | IDYA |
|---|---|---|
| Shares Outstanding | 374M | 96M |
| Net Income Growth | -332.3% | – |
| EPS Growth | -453.4% | – |
BHC vs IDYA: stock comparison and AI forecast
Which is bigger, BHC or IDYA?
BHC and IDYA have similar market capitalizations ($3.00B and $3.05B).
Which stock performed better over the last six months, BHC or IDYA?
Over the last six months BHC returned +45.0% and IDYA +9.5%.
Which one does Intratio's AI model rank higher, BHC or IDYA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.